A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the destruction authority of the Secretary of Health and Human Services to articles that present a significant public health concern, and for other purposes.
Sponsored by
Sen. Scott, Rick [R-FL]
ID: S001217
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Invalid Date
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
Committee Review
Floor Action
Passed Senate
House Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
No summary available
💰 Campaign Finance Network
No campaign finance data available for Sen. Scott, Rick [R-FL]
Industry Impact
Which industries are materially affected by specific provisions in this bill. 3 harmed.
- −Pharmaceuticalsconfidence 0.90
Section 2(a)(2) amends the FD&C Act to replace 'drug or device' with 'drug, device, or other article' in the destruction authority, expanding the scope of articles subject to destruction by HHS. This could lead to increased regulatory risk and potential destruction of pharmaceutical products deemed a public health concern, imposing costs on the pharmaceutical industry.
- −Medical Devicesconfidence 0.90
Section 2(a)(2) similarly expands the destruction authority to include 'device' among other articles, allowing HHS to destroy medical devices deemed a public health concern. This introduces regulatory risk and potential losses for medical device manufacturers.
- −Biotech & Researchconfidence 0.85
Biotech products (e.g., biologics, gene therapies) are regulated as drugs or devices under the FD&C Act. The expansion of destruction authority to 'other articles' could apply to biotech products, creating regulatory uncertainty and potential enforcement actions.
Who funds the sponsor on these industries
For each industry this bill affects, here's what the sponsor (Sen. Scott, Rick [R-FL])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.
Industries this bill HARMS
- Medical Devices$517from 18 contributions
- WEITZ, BRAD$202
- KING, LINDA G. MS.$200
- VERA, OSCAR$115
- Pharmaceuticals$100from 2 contributions
- NOWELL, RICHARD P. MR.$100
- from 3 contributions
- CAMPBELL, DEBORAH$72